Scholars Central

Conference abstractPublished 10 Aug 2015

The potential role of β-glycosphingolipids in the immune system: Novel secondary messengers

Authors: Yaron Ilan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Oral Immune therapy is an approach to treat autoimmune, infectious, malignant and inflammatory diseases. It is an active process that uses the inherent ability of the GI tract’s immune system to control unwanted systemic immune responses by inducing regulatory T cells in an antigen-specific manner. Dendritic cells and Natural Killer T cells play an important role in this interaction. Glycosphingolipids were shown as secondary messengers of the immune system affecting the dendritic cells-natural killer cells interplay thereby underlying the interaction between the innate and the adaptive immune systems and promoting oral immune therapy. Glycosphingolipids were also shown as potent adjuvant in the gut. Preclinical studies supports the role of glycosphingolipids in alleviating immune-mediated colitis, autoimmune hepatitis, type 2 diabetes and fatty liver disease. In addition, they were shown to promote the anti-tumor immunity in animal models of primary liver cancer. Recent clinical trials support a similar effect in humans with immune-meidated disorders. Patients with Gaucher disease, who have elevated levels of glucocerebroside in their serum, were shown to have altered immune response and to have an evolutionary advantage, further supporting the immune modulatory role of the sphingolipids. In summary, balance between various glycosphingolipids is important for immune homeostasis. Gaucher, administration of Ã?²-glycosphingolipids, compounds that alter enzymes that increase or decrease sphingolipids levels, skew the immune balance. The effect of Ã?²-glycosphingolipids may be associated with promotion of the DC-NKT interaction, Tregs and or via alteration of lipid rafts and intracellular signaling. Ã?²-glycosphingolipids can serve as potent adjuvants/immune modulators for immune therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Glycobiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Yaron Ilan”